NeuBase is accelerating the genetic revolution by developing a new class of precision genetic medicines that can be designed to increase, decrease, or change gene function, as appropriate, to resolve genetic defects that drive disease.

Pharmaceutical

NeuBase Therapeutics

Dietrich A. Stephan

Nathan T.

Lindsey Spiker

Steven Murphy

Kayla Williams

Chelsea Martinez

Barry Badeau

William Riedl

Lydia(Lyuqin) Chen

Jeremy Gleaton

Sally Edmonds

Ranajoy Sarkar

Jonathan Leung

John J. Thomas

Dov Goldstein

Jessica Balogh

Eric Richman

Todd P. Branning

Sandra Rojas-Caro

The leadership team at NeuBase Therapeutics has a history of working in the biopharmaceutical industry and in corporate development. They have experience with companies such as Helsinn Therapeutics, Sapphire Therapeutics, and Novartis. They also have experience in human genetics and biochemistry from their education at The Rockefeller University and the University of Aberdeen.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at NeuBase Therapeutics

Board of Directors

CEO and Executive Team